Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Drs. Boland and Mahipal is a professional medical and clinical research entity led by oncologists Dr. Patrick Boland and Dr. Amit Mahipal. The group specializes in medical oncology with a specific focus on gastrointestinal malignancies, including colorectal and pancreatic cancers. They are extensively involved in the design and execution of early-phase clinical trials and investigator-initiated research. The entity typically operates within the infrastructure of major academic centers like the Rutgers Cancer Institute of New Jersey and the University of Rochester. Their work contributes to the clinical evaluation of novel oncology therapeutics, bridging the gap between experimental drug development and patient care. The group is recognized for its expertise in managing complex clinical protocols for advanced solid tumors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Drs. Boland, Mahipal.